Metabolic stress results in p53 activation, which can trigger cell-cycle arrest, ROS clearance, or apoptosis. However, what determines the p53-mediated cell fate decision upon metabolic stress is not very well understood. We show here that PGC-1a binds to p53 and modulates its transactivation function, resulting in preferential transactivation of proarrest and metabolic target genes. Thus glucose starvation results in p53-dependent cell-cycle arrest and ROS clearance, but abrogation of PGC-1a expression results in extensive apoptosis. Additionally, prolonged starvation results in PGC-1a degradation concomitant with induction of apoptosis. We have also identified RNF2, a Polycomb group (PcG) protein, as the cognate E3 ubiquitin ligase. Starvation of mice where PGC-1a expression is abrogated results in loss of p53-mediated ROS clearance, enhanced p53-dependent apoptosis, and consequent severe liver atrophy. These findings provide key insights into the role of PGC-1a in regulating p53-mediated cell fate decisions in response to metabolic stress.
INTRODUCTION
The tumor suppressor p53 plays a major role in mediating cellular response to diverse intracellular and extracellular stresses including DNA damage, hypoxia, and oncogene expression by inducing the transcription of a variety of genes that regulate multifarious cellular processes including cell-cycle progression, apoptosis, and genomic stability. Temporal regulation of diverse sets of target genes is usually achieved by posttranslational modifications of p53 and through its interaction with other cellular proteins (Smeenk and Lohrum, 2010) .
PPAR gamma coactivator-1 (PGC-1) is a small family of transcriptional coactivators that play a critical role in the control of glucose, lipid, and energy metabolism. There are three known isoforms of PGC-1: PGC-1a, PGC-1b, and PGC-1-related coactivator (PRC). PGC-1a serves a critical role in the augmentation of mitochondrial biogenesis, cellular respiration rates, and energy substrate uptake and utilization. PGC-1a exerts these pleiotropic effects by coactivating transcription factors involved in the control of cellular metabolism including PPARg (Puigserver et al., 1998) , NRF-1 , NRF-2 , FOXO1 (Puigserver et al., 2003) , etc.
Emerging data suggest that p53 plays an important role in regulating cellular metabolism (Vousden and Ryan, 2009) . Several p53 target genes have been identified including TIGAR (Bensaad et al., 2006) , Sco2 (Matoba et al., 2006) , PGM (Kondoh et al., 2005) , sestrin1 and sestrin2 (Budanov et al., 2004; Sablina et al., 2005) , etc., which play a key role in homeostatic regulation of energy production and coordinate the rate of reactive oxygen species (ROS) biogenesis and clearance. Since both p53 and PGC-1a are key players in transcriptional regulation of cellular metabolism, we investigated their functional interplay. We found that p53 recruits PGC-1a to boost its metabolic functions. Thus when PGC-1a binds to p53, it is preferentially recruited to the promoters of its proarrest and metabolic target genes. Consequently, in the presence of PGC-1a, p53-mediated cell-cycle arrest and ROS clearance is promoted in response to metabolic stress. However, upon prolonged starvation, PGC-1a undergoes degradation via ubiquitin-proteasome pathway, leading to induction of apoptosis.
RESULTS

PGC-1a Can Serve as a Coactivator of Tumor Suppressor p53
Since PGC-1a serves as a key coactivator in transcriptional regulation of cellular metabolism, we investigated whether PGC-1a can serve as a p53 coactivator by carrying out reporter assay with a p53-specific luciferase reporter, PG13-Luc. We found that the transcriptional ability of p53 was enhanced in the presence of PGC-1a, and this increase was dose dependent ( Figure 1A ). Similar results were obtained with p21-Luc (Figure 1B) . We also looked at the effect of PGC-1a on the transcriptional activity of p53 induced under metabolic stress condition. Glucose starvation is known to induce p53 protein levels in an AMP-activated protein kinase (AMPK)-dependent manner (Jones et al., 2005; Okoshi et al., 2008) . We stably transfected HepG2 (liver carcinoma; p53 wild-type) cells (pooled puromycin-resistant population) with control (scrambled) or PGC-1a shRNA. Transfection of PGC-1a shRNA resulted in the suppression of endogenous PGC-1a, but not so in control shRNA-transfected cells (see Figure S1A available online). When HepG2 control cells were subjected to glucose starvation, we found both p53 and PGC-1a levels to be significantly induced as previously reported (Jones et al., 2005; Okoshi et al., 2008; Yoon et al., 2001; Jager et al., 2007) , but under similar conditions only p53 was induced in PGC-1a knockdown cells ( Figure 1C ).
In both HepG2 control and PGC-1a knockdown cells, upon glucose starvation, AMPK was phosphorylated at Thr172 and increased Ser79 phosphorylation of its substrate acetyl CoA carboxylase was observed, indicating activation of AMPK. Glucose deprivation also results in mTOR pathway inhibition (Inoki et al., 2003) . We used p70S6K phosphorylation at Thr389 as a readout of mTOR activity (Brown et al., 1995) . p70S6K activity can in turn be determined by phosphorylation of ribosomal S6 protein at Ser235/236 (Dufner and Thomas, 1999) . In both HepG2 control and PGC-1a knockdown cells, upon glu- Figure 1 . PGC-1a Enhances p53 Transcriptional Activity (A) PG13-Luc was cotransfected into H1299 cells (non-small cell lung carcinoma; p53 null) with p53 and PGC-1a constructs as indicated. Luciferase assay was carried out 24 hr posttransfection. Error bars are means ± SD of three independent experiments with duplicate samples. (B) p21-Luc was cotransfected into H1299 cells with p53 and PGC-1a constructs as indicated. Twenty-four hours later luciferase assay was carried out. Error bars are means ± SD of three independent experiments with duplicate samples. (C) HepG2 control (HepG2) and PGC-1a knockdown (HepG2 PGC-1akd) cells were glucose starved for indicated time points, and immunoblotting was performed for the indicated proteins from cell lysates. (D) p21-Luc was transfected in both HepG2 control (HepG2) and PGC-1a knockdown (HepG2 PGC-1akd) cells. Posttransfection, glucose starvation was carried out for indicated time points followed by luciferase assay. Error bars are means ± SD of three independent experiments with duplicate samples. Please see also Figure S1 .
cose starvation, inhibition of p70S6K phosphorylation and S6 phosphorylation was observed, indicating inhibition of mTOR pathway. Similar results were obtained with other forms of metabolic stress, including serum starvation and cold shock (Figures S1B and S1D). To assess p53 transcriptional activity, HepG2 control and PGC-1a knockdown cells were transfected with p21-Luc followed by glucose starvation for indicated time points. We found that the ability of p53 to transactivate the p21 promoter was significantly increased with increasing duration of glucose starvation. However, in PGC-1a knockdown cells, p53 transactivation ability was severely impaired (Figure 1D ). To exclude off-target effects of shRNA, two other PGC-1a shRNAs were used, and similar results were obtained (data not shown). Similar results were also obtained with other forms of metabolic stress (Figures S1C and S1E). All of these results suggest that PGC-1a can serve as a p53 coactivator.
PGC-1a Binds to p53
Since PGC-1a enhances p53-mediated transactivation, we next tested whether PGC-1a physically interacts with p53 by carrying out immunoprecipitations. We found that PGC-1a coimmunoprecipitated with p53 ( Figure 2A , left panel). We also performed the reverse coimmunoprecipitation (coIP) experiment in which p53 coimmunoprecipitated with PGC-1a ( Figure 2A , right panel).
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We further examined the interaction between endogenous p53 and PGC-1a under glucose starvation conditions. Here also we found that PGC-1a coimmunoprecipitated with p53 ( Figure 2B , left panel). Similar results were obtained in the reverse coIP experiment ( Figure 2B , right panel). To confirm that p53 directly interacts with PGC-1a, in vitro GST pull-down assay was performed ( Figure 2C ). Our results corroborated that p53 directly interacts with PGC-1a.
To map the domain of p53 to which PGC-1a binds, we carried out GST pull-down experiments. The GST-p53 segment containing amino acids 1-43 specifically bound to the PGC-1a protein ( Figure 2D ). Using GST pull-down experiments we also mapped the domain of PGC-1a which binds p53. The GST-PGC-1a segment containing amino acids 1-200 specifically bound to the p53 protein ( Figure 2E ). When an N-terminal deletion mutant of PGC-1a (DN-PGC-1a; amino acids 201-797) was used for p53-specific reporter assay, no transactivation was observed ( Figure 2F ).Taken together, these results indicate that N-terminal activation domain of PGC-1a binds to the N-terminal transactivation domain of p53 and is essential for the coactivator function of PGC-1a.
Since p53 recruits p300 coactivator for its transactivation function (Gu et al., 1997; Lill et al., 1997) and PGC-1a also binds to p300 , we examined the role of p300 in p53-PGC-1a complex. We stably transfected H1299 cells with control or p300 shRNA. Transfection of p300 shRNA resulted in the suppression of endogenous p300, but not in control shRNA-transfected cells ( Figure S2A ). Using these cells, immunoprecipitation was carried out with anti-p53 antibody. In control cells we could detect p300 in the immunoprecipitated complex along with p53 and PGC-1a, but in p300 knockdown cells no p300 could be detected ( Figure S2B , left panel). Similar results were also obtained in the reverse coIP experiment with anti-PGC-1a antibody ( Figure S2B , right panel). To further investigate the role of p300, luciferase reporter assay was carried out. In control cells, p53 could transactivate the luciferase reporter and the transcriptional ability of p53 was enhanced in the presence of PGC-1a, and this increase was dose dependent (Figure S2C ). However, in p300 knockdown cells the transcriptional ability of p53 was severely impaired but was restored significantly in a dose-dependent manner in the presence of increasing amounts of PGC-1a. Thus we concluded that p300 is not required for the formation of p53-PGC-1a complex but is required for optimal functioning of the complex.
PGC-1a Determines the Specificity of p53-Mediated Transactivation Since our results established that PGC-1a binds to p53, we next determined its effect on p53-mediated transactivation. We stably transfected HepG2 cells (pooled puromycin-resistant population) with control (luciferase) or PGC-1a shRNA. These cells were then subjected to different forms of metabolic stress including glucose starvation and serum starvation, and the levels of different p53 target genes including proarrest, proapoptotic, and metabolic targets were analyzed. The proarrest and metabolic target genes such as p21, GADD45, TIGAR, Sco2, and sestrin 2 were rapidly induced at early time points (24 and 36 hr), but at extended periods of starvation (48 and 72 hr) their levels reduced drastically ( Figure 3A , upper panel; 3B left panel and S3A). On the other hand p53 pro-apoptotic target genes such as Bax, Noxa and Puma were induced only at extended periods of starvation ( Figure 3A lower panel, 3B left panel and S3A). In HepG2 PGC-1a knockdown cells no induction of the pro-arrest and metabolic target genes was observed at any of the time points whereas the pro-apoptotic target genes were rapidly induced from early time points itself ( Figure 3A lower panel, 3B right panel and S3A). In HepG2 control cells PGC-1a transcript levels were induced at 24 hr and remained steady throughout the rest of time course but the protein levels reduced drastically at extended periods of starvation ( Figure 3A lower panel, Figure 3B , left panel; and Figures S3A and S3B). Similar results were also obtained in other cell types (Figures S3E, S3F, S3I, and S3J). The transcript level changes of proarrest, proapoptotic, and metabolic target genes were a p53-dependent phenomenon, as these changes were not observed when p53 expression was abrogated by RNAi (Figures S4A and S4B) .
We also measured the DNA binding activity of p53 induced in response to glucose starvation on the promoters of p53 target genes. Upon glucose starvation, p53 bound to the promoter of its target genes with kinetics similar to that of mRNA induction seen above ( Figure 3C ). To ascertain the presence of PGC-1a in the transcription complex, we performed ''ReChIP'' experiments using anti-PGC-1a antibody. PGC-1a was detected only at the promoters of p21 and TIGAR at an early time point (36 hr), but not at the promoters of Bax and Puma at any time point ( Figure 3D ). Moreover, when p53 expression was abrogated by RNAi, no PGC-1a was detected at p21, TIGAR, Bax, or Puma promoters at any point of starvation ( Figure S4C ). Taken together, these data demonstrate that PGC-1a selectively enhances p53-mediated transactivation of its proarrest and metabolic target genes at early time points of starvation, but at extended periods of starvation PGC-1a protein is downregulated and p53 is preferentially recruited to the promoter of its proapoptotic targets.
PGC-1a Promotes the Cell-Cycle Arrest and Metabolic Functions of p53
We next examined the effects of PGC-1a on p53-mediated stress response. In HepG2 control cells, glucose starvation induced a pronounced arrest in G1 phase of the cell cycle at 24-36 hr ( Figure 4A ), after which there was a marked increase in the apoptotic population. In the case of HepG2 PGC-1a knockdown cells, a significant population of apoptotic cells was present from an early time point of starvation, which increased further at later time points. TUNEL staining also confirmed these results ( Figure 4B ). In HepG2 control cells, the ROS levels were negligible at early time points of starvation (24 and 36 hr) as measured by DCFDA staining, but at 48 hr the ROS levels were considerably higher, which further increased at 72 hr ( Figure 4C ). However in HepG2 PGC-1a knockdown cells, significantly higher ROS levels were detected at early time points of starvation (24 and 36 hr), which increased further at extended time points. Similar results were obtained upon serum starvation (Figures S3C and S3D) . Similar results were also obtained in other cell types (Figures S3G, S3H, S3K, and S3L) . Taken together, these results indicate that PGC-1a
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PGC-1a, a Key Modulator of p53 (A) H1299 cells were infected with indicated adenoviruses for 24 hr. The cells were then harvested and subjected to immunoprecipitations using anti-p53 antibody (left panel) or anti-PGC-1a antibody (right panel), and western blots were performed for the indicated proteins. (B) HepG2 cells were cultured in medium containing 25 mM or 5 mM for 24 hr. The cells were harvested and subjected to immunoprecipitations using anti-p53 antibody (left panel) or anti-PGC-1a antibody (right panel), and western blots were performed for the indicated proteins. (C) GST, GST-p53, and His-PGC-1a proteins were run on SDS-PAGE and stained with Coomassie blue (left panel). GST pull-down assay was performed with GST or GST-p53 in the presence or absence of His-PGC-1a. Following the pull-down, western blots were performed for the indicated proteins (right panel). (D) H1299 cells were transfected with constructs expressing full-length or different domains of p53 as GST fusion protein. Empty vector transfection was also carried out as a negative control. Six hours posttransfection, the cells were infected with Ad-PGC-1a or Ad-GFP. Twenty-four hours postinfection, cell lysates were prepared and subjected to GST pull-down followed by immunoblotting for the indicated proteins.
PGC-1a, a Key Modulator of p53 enhances the proarrest and metabolic functions of p53 at early periods of metabolic stress while at later time points PGC-1a protein gets degraded, resulting in induction of apoptosis. The ROS clearance and apoptosis observed upon starvation are primarily a p53-dependent phenomenon, as RNAi-mediated knockdown of p53 expression resulted in significantly attenuated apoptosis and elevated ROS levels ( Figures S4D and  S4E , left panel). To confirm that DCFDA-positive cells represent ROS positive population, we carried out staining with an alternate ROS-sensitive dye DHE, and similar results were obtained ( Figure S4E , right panel). We also confirmed that DCFDA-positive cells contain higher ROS levels sufficient for apoptosis, as treatment of glucose-starved cells with ROS scavenger Tiron at extended periods of starvation reduced the DCFDA-positive population ( Figure S4F ) as well as the apoptotic population ( Figure S4G ).
Upon Prolonged Starvation, PGC-1a Protein Undergoes Degradation via Ubiquitin-Proteasome Pathway
Since ubiquitin-mediated proteasome degradation pathway is a frequently engaged mechanism for protein downregulation, we investigated the potential role of the proteasome in stressinduced PGC-1a protein degradation. We found that loss of PGC-1a triggered by metabolic stress at the 72 hr time point was significantly attenuated by the proteasome inhibitor MG132, resulting in elevated p21 levels similar to those of the 36 hr time point ( Figure 5A ). However, Bax levels were diminished similar to those at 36 hr in MG132-treated HepG2 cells ( Figure 5A ). Furthermore, RT-qPCR analysis showed that MG132 treatment did not affect the PGC-1a mRNA levels, induced the p21 mRNA levels, and curtailed the induction of Bax mRNA (Figure 5B) , supporting the hypothesis that the preferential recruitment of p53 to p21 promoter over bax promoter results from MG132-mediated stabilization of PGC-1a protein. This was confirmed by quantitative ChIP assays ( Figure 5C ). Moreover, MG132-mediated stabilization of PGC-1a could indeed attenuate the p53-mediated apoptosis upon prolonged metabolic stress ( Figure 5D ). If the diminished levels of PGC-1a at extended periods of stress were restored by exogenous overexpression, p21 was induced similar to the levels at the 36 hr time point while attenuating the induction of Bax levels ( Figures S5A and S5B) . Additionally, PGC-1a overexpression also protected the cells from apoptosis ( Figure S5C ).
We next determined whether PGC-1a undergoes polyubiquitination prior to degradation. Glucose starvation of HepG2 cells revealed that PGC-1a undergoes extensive ubiquitination after prolonged starvation (72 hr), while no such ubiquitinated forms were observed at 36 hr ( Figure 5E ). Thus, we concluded that the PGC-1a protein is targeted for degradation during prolonged metabolic stress due to activation of an ubiquitin-proteasome pathway.
RNF2 Plays a Key Role in PGC-1a Degradation
To identify the ubiquitin ligase responsible for stress-induced PGC-1a degradation, we carried out a yeast two-hybrid screen. One of the clones obtained from the screen was RNF2. RNF2 is a Polycomb group protein that possesses E3 ubiquitin ligase activity (Suzuki et al., 2002; Wang et al., 2004) . To test if RNF2 interacts with PGC-1a, immunoprecipitation was carried out using PGC-1a antibody ( Figure 6A, left panel) . Our results showed that RNF2 interacts with PGC-1a. Similar results were obtained by reverse coIP experiments ( Figure 6A, right panel) . To study the PGC-1a-RNF2 interaction under physiological conditions, we carried out immunoprecipitations over the time course of starvation using PGC-1a antibody. Here we found that only at extended periods of starvation (48 and 72 hr) RNF2 coimmunoprecipitated with PGC-1a ( Figure 6B, left panel) . Similar results were obtained in the reverse coIP experiment ( Figure 6B , right panel). To investigate the effect of RNF2 on PGC-1a protein, we stably transfected HepG2 cells (pooled puromycin-resistant population) with control (luciferase) or RNF2 shRNA. Transfection of RNF2 shRNA resulted in the suppression of endogenous RNF2, but not so in control shRNAtransfected cells ( Figure 6C ). In HepG2 control cells, PGC-1a was induced at 24 hr but reduced drastically at extended periods of starvation. On the other hand, in HepG2 RNF2 knockdown cells PGC-1a was induced at 24 hr and remained steady throughout the rest of the starvation period. These results indicate that RNF2 targets PGC-1a for degradation at extended periods of starvation.
To examine the effect of RNF2 on the PGC-1a-mediated cell fate decision, we subjected the HepG2 control and RNF2 knockdown cells to glucose starvation and carried out cell-cycle analysis. Here we found that in HepG2 RNF2 knockdown cells there was no significant apoptosis, unlike control cells, at 72 hr of starvation ( Figure 6D ). We also looked at the transcript levels of p21, TIGAR, Bax, PGC-1a, and RNF2 over the time course of starvation. In HepG2 control cells, p21 and TIGAR levels were induced at early time points up to 36 hr, but subsequently their levels decreased rapidly. However, in RNF2 knockdown cells, p21 and TIGAR levels were induced at early time points and remain steady over the rest of the time course of starvation ( Figure 6E ). Bax levels in HepG2 control cells were induced only at extended periods of starvation (48 and 72 hr), but in RNF2 knockdown cells Bax levels were not induced at any period of starvation. PGC-1a levels were induced at 24 hr of starvation and remained steady over the rest of the time course of starvation in both HepG2 control and RNF2 knockdown cells. RNF2 levels remain unchanged over the course of starvation in HepG2 control cells, while its levels in RNF2 knockdown cells were substantially reduced. To exclude off-target effects of shRNA, two other RNF2 shRNAs were used, and similar results were obtained (data not shown). In conclusion, RNF2 targets PGC-1a for (E) H1299 cells were transfected with constructs expressing full-length or different domains of PGC-1a as GST fusion protein. Six hours posttransfection, the cells were infected with Ad-p53 or Ad-GFP. Twenty-four hours postinfection, cell lysates were prepared and GST pull-down was carried out followed by immunoblotting for the indicated proteins. (F) PG13-Luc was cotransfected into H1299 cells with p53 and PGC-1a or DN-PGC-1a constructs as indicated. Twenty-four hours posttransfection, luciferase assay was carried out. Error bars are means ± SD of three independent experiments with duplicate samples. Please see also Figure S2 . (HepG2) and PGC-1a knockdown cells (HepG2 PGC-1akd) were glucose starved for indicated time points. Total RNA was isolated and relative mRNA levels were analyzed by RT-qPCR for the indicated genes. Error bars are means ± SD of three independent experiments with triplicate samples. (B) HepG2 control (HepG2) and PGC-1a knockdown cells (HepG2 PGC-1akd) were glucose starved for indicated time points, and western blotting was performed for the indicated proteins from cell lysates.
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PGC-1a, a Key Modulator of p53 degradation at extended periods of starvation, leading to induction of apoptosis.
PGC-1a Modulates p53-Mediated Starvation Response In Vivo
To study the role of PGC-1a in metabolic stress response in vivo, we used siRNA to knock down PGC-1a expression in mice, and poststarvation the transcript levels of different p53 target genes were analyzed in liver. Injection of PGC-1a siRNA resulted in the suppression of endogenous PGC-1a in mice liver, but not so in control (luciferase) siRNA ( Figure 7A ). In control mice, the transcript levels of proarrest and metabolic target genes were significantly induced at early point of starvation (1 day), but at later time points (2 and 3 days) there was a sharp drop ( Figure 7A ). In the case of PGC-1a knockdown mice, no induction of p21, Sco2, or sestrin 2 was observed at any point of starvation. In control mice, the transcript levels of bax were induced only at extended periods of starvation (2 and 3 days), but in the case of PGC-1a knockdown mice, significant induction of bax was seen from early point of starvation, which increased further at later time points. The transcript level change of p21, Sco2, sestrin 2, and bax was a p53-dependent phenomenon, as these changes were not observed in p53 À/À mice at similar time points of starvation ( Figure S6A ). We also looked at the PGC-1a protein levels in control, PGC-1a knockdown, wild-type, and p53 À/À mice ( Figure 7B and Figure S6B ). In control, wild-type, and p53 À/À mice, the PGC-1a protein was induced significantly at an early time point but decreased sharply at later time points. In PGC-1a knockdown mice, no PGC-1a protein was detectable at any of the time points of starvation. We also measured the ROS levels and extent of apoptosis in the hepatocytes of these mice. In control mice, no significant amount of ROS was detected at early point of starvation, but at later time points there was a sharp increase in ROS levels concomitant to a decrease in PGC-1a protein levels ( Figure 7C ). The ROS levels were significantly higher in PGC-1a knockdown mice at early point of starvation, which increased further at later time points. In control mice, the percentage of hepatocytes undergoing apoptosis was minimal at an early time point of starvation but increased substantially at later time points, concomitant to a decrease in PGC-1a protein levels ( Figure 7D ). However, in the case of PGC-1a knockdown mice, the extent of apoptosis at an early time point was much higher, which increased further at later time points. We also measured the ROS levels and extent of apoptosis in the hepatocytes of p53 À/À mice. In these mice the ROS levels were higher from early point of starvation itself as compared to wild-type mice ( Figure S6C ). The ROS levels increased further after 2 and 3 days, but it did not reach the levels seen in wild-type mice. This suggests that the ROS clearance at early point of starvation is primarily a p53-dependent function but at later time points when PGC-1a gets degraded, p53 triggers apoptosis, which also contributes to ROS levels seen in wildtype mice. This was corroborated by our TUNEL assays ( Figure S6D ).
To assess liver function, we carried out pyruvate tolerance test (PTT), which is a measure of gluconeogenic ability. Our PTT results show that after 1 day of starvation the gluconeogenic ability of PGC-1a knockdown mice was much reduced as compared to control mice ( Figure 7E ). After 3 days of starvation, the gluconeogenic ability of PGC-1a knockdown mice was further lower than that of control mice. We also carried out metabolite profiling of the liver from control and PGC-1a knockdown mice ( Figure 7F ). We found that after 1 day of starvation the levels of gluconeogenic intermediates were significantly higher in control mice as compared to PGC-1a knockdown mice, along with accumulation of precursors for gluconeogenesis including alanine and lactate in PGC-1a knockdown mice. After 3 days of starvation, the levels of gluconeogenic intermediates in the liver of PGC-1a knockdown mice were further lower than control mice. We also carried out PTT with p53 À/À mice. Here we found that after 1 day of starvation the gluconeogenic ability of p53
mice was lower than wild-type mice ( Figure S6E ). However, after 3 days of starvation the gluconeogenic ability of wild-type mice was lower than that of p53 À/À mice. We also carried out metabolite profiling of the liver from wild-type and p53 À/À mice (Figure S6F) . We found that after 1 day of starvation the levels of gluconeogenic intermediates were higher in wild-type mice as compared to p53 À/À mice. After 3 days of starvation, the levels of gluconeogenic intermediates in the liver of wild-type mice were lower than p53 À/À mice, along with the accumulation of precursors for gluconeogenesis. Taken together, the induction of proarrest and metabolic target genes by p53 in a PGC1a-dependent manner plays a critical role in maintaining liver function. Upon extended periods of starvation, PGC-1a gets degraded, leading to induction of p53-mediated apoptosis resulting in liver atrophy.
To study the role of RNF2 in starvation response in vivo, we carried out similar assays as described above. Injection of RNF2 siRNA resulted in the suppression of endogenous RNF2, but not so in control siRNA ( Figure 7G ). In RNF2 knockdown mice, the proarrest and metabolic target genes were induced at an early time point similar to control mice, but at later time points their levels increased further, contrary to what was observed in control mice ( Figure 7H ). In RNF2 knockdown mice, no induction of bax was observed at any point of starvation period. We also looked at the PGC-1a transcript and protein levels in these mice ( Figures 7G and 7H) . In control mice, the PGC-1a transcript and protein levels were induced significantly at an early time point, but protein levels decreased sharply at later time points while transcript levels remained steady. In RNF2 knockdown mice, both PGC-1a transcript and protein levels were induced at an early time point and remained steady (C) HepG2 control (HepG2) and PGC-1a knockdown cells (HepG2 PGC-1akd) were glucose starved for indicated time points. ChIP assay was then performed with p53 antibody or control IgG antibody. The fold enrichment of coprecipitating DNA was determined by qPCR for the indicated promoters. Error bars are means ± SD of three independent experiments with triplicate samples. (D) Part of the chromatin immunoprecipitated with p53 antibody was again subjected to ChIP using control IgG or PGC-1a antibody. The fold enrichment of coprecipitating DNA was determined by qPCR for indicated promoters. Error bars are means ± SD of three independent experiments with triplicate samples. Please see also Figures S3 and S4.
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PGC-1a, a Key Modulator of p53 throughout the rest of the time course of starvation. This clearly indicates that RNF2 plays a key role in regulating PGC-1a protein levels in vivo. We also measured the ROS levels and extent of apoptosis in the hepatocytes of these mice. In RNF2 knockdown mice, no significant amount of ROS was detected at early point of starvation, as in control mice, but at later time points when there was a sharp increase in ROS levels in control mice, only a marginal increase was observed in RNF2 knockdown mice ( Figure 7I ). The percentage of hepatocytes undergoing apoptosis was minimal at an early time point of starvation in RNF2 knockdown mice, similar to what was observed in control mice, but at later time points when there was a substantial increase in the extent of apoptosis in control mice, only a slight increase in apoptosis was observed in RNF2 knockdown mice ( Figure 7J ). We also carried out PTT in RNF2 knockdown mice. Our PTT results show that after 1 day of starvation the 
PGC-1a, a Key Modulator of p53 gluconeogenic ability of RNF2 knockdown mice was similar to control mice ( Figure 7K ). After 3 days of starvation, the gluconeogenic ability of RNF2 knockdown mice was better than that of control mice. We also carried out metabolite profiling of the liver from control and RNF2 knockdown mice. We found that after 1 day of starvation the levels of gluconeogenic intermediates (A-C) HepG2 cells were subjected to glucose starvation for 0, 36, and 72 hr, and MG132 (10 mM) was added during the last 10 hr prior to the end of the 72 hr time point. The cells were then harvested, and western blotting (A), RT-qPCR (B), and ChIP assay (C) were performed for the indicated genes. (D) HepG2 cells were subjected to glucose starvation for 0, 36, and 72 hr, and MG132 (10 mM) was added during the last 10 hr prior to the end of the 72 hr time point. The cells were then harvested, stained with propidium iodide, and analyzed by FACS. The data shown are representative of three independent experiments. (E) HepG2 cells were subjected to glucose starvation for the indicated time points and treated with MG132 (10 mM) for the last 10 hr. Cell lysates were prepared and immunoprecipitation was carried out with anti-PGC-1a antibody followed by immunoblotting with anti-ubiquitin antibody. Please see also Figure S5 .
PGC-1a, a Key Modulator of p53 (E) HepG2 control (HepG2) and RNF2 knockdown cells (HepG2 RNF2kd) were glucose starved for indicated time points. Total RNA was isolated, and relative mRNA levels were analyzed by RT-qPCR for the indicated genes. Error bars are means ± SD of three independent experiments with triplicate samples.
PGC-1a, a Key Modulator of p53 were similarly elevated in both control and RNF2 knockdown mice ( Figure 7L ). After 3 days of starvation, the levels of gluconeogenic intermediates in the liver of control mice were significantly lower than in RNF2 knockdown mice. Moreover, there was accumulation of precursors of gluconeogenesis in control mice. Thus our results indicate that RNF2 plays a key role in modulating PGC-1a protein levels and function in vivo. Abrogation of RNF2 expression prevents PGC-1a protein degradation upon prolonged starvation, which mitigates liver atrophy.
We also looked at the ability of control, PGC-1a knockdown, RNF2 knockdown, wild-type, and p53 À/À mice to mount adaptive metabolic responses upon cold exposure ( Figures S7A-S7L ). Brown adipose tissue (BAT) is the primary site for adaptive metabolic responses upon cold exposure. Upon exposure to low temperatures, lipid stored in BAT is metabolized. Here also we found that upon exposure to cold, PGC-1a is rapidly induced but is subjected to similar regulation by RNF2, as was observed in liver (Figures S7B and S7F) . We also found that adaptive metabolic responses to cold are primarily a function of PGC-1a, as degradation or abrogation of PGC-1a expression results in significantly higher ROS levels and reduced lipid breakdown ( Figures S7C and S7D ), while abrogation of RNF2 expression results in reduced ROS levels and enhanced lipid breakdown even at later time points ( Figures  S7G and S7H ). The stress response to cold is augmented by p53 induced in response to cold through transactivation of its metabolic target genes which keep ROS levels in check and aid in lipid assimilation ( Figures S7A, S7C , S7D, S7I, S7K, and S7L).
DISCUSSION
A critical unresolved issue of the metabolic stress response is how the resulting upregulation of p53 can lead either to cell-cycle arrest and ROS clearance or to apoptosis. This regulation can be achieved by posttranslational modifications or p53-binding proteins capable of modulating p53 transcriptional activity. In the case of genotoxic stress conditions, hCAS/CSE1L, a p53 binding protein, promotes the induction of proapoptotic p53 target genes such as PIG3 and p53AIP1 (Tanaka et al., 2007) . Similarly, p53 acetylation at lysine 120 by Tip60 under genotoxic stress conditions promotes favorable induction of proapoptotic p53 target genes such as Bax and Puma (Sykes et al., 2006; Tang et al., 2006) . Our data reveal that PGC-1a regulates Lys120 acetylation of p53. Under starvation conditions when PGC-1a is bound to p53, Lys120 acetylation of p53 cannot take place ( Figure S5A ). At extended periods of starvation when PGC-1a protein is degraded, Lys120 acetylation of p53 is facilitated, thereby triggering the onset of p53-dependent apoptosis ( Figures S5B and S5C ) through preferential recruitment of AcK120-p53 to the promoters of its proapoptotic targets such as bax ( Figure S5D ). If at extended periods of starvation the diminished PGC-1a levels are restored, then Lys120 acetylation of p53 is inhibited, thereby attenuating p53-dependent apoptosis. Thus, by regulating posttranslational modification of p53, PGC-1a contributes to p53 target selection. We also investigated the effect of PGC-1 family member PGC-1b on p53 transactivation function. Even though PGC-1b is induced upon glucose starvation, it cannot serve as a p53 coactivator (Figures S2D and S2E) . Also upon exogenous overexpression, we could not detect any effect of PGC-1b on p53 transactivation function ( Figure S2F ). Our data show that there is no correlation between the induced p53 protein levels and dynamics of PGC-1a transcript and protein levels upon glucose starvation, as PGC-1a transcript and protein levels follow a similar kinetics also in the absence of p53 ( Figures S4A, S4B, S6A, and S6B) . Induction of PGC-1a under starvation conditions is a cyclic AMP response element binding protein (CREB)-mediated transcriptional event (Herzig et al., 2001) , while p53 induction under starvation condition is a posttranslational event mediated by AMPK-dependent phosphorylation (Jones et al., 2005) . However, starvation-induced PGC-1a in p53 null conditions cannot trigger cell-cycle arrest but exhibits limited p53-independent ROS clearance ability (Figures S4D and S4E) .
PGC-1a is also known to interact with FOXO1 and HNF4, two key players in the regulation of metabolic processes (Puigserver et al., 2003; Yoon et al., 2001 ). We also found that upon glucose starvation when predominantly the unphosphorylated form of FOXO1 is present, the induced levels of PGC-1a interact with FOXO1, which is distinctive of its interaction with p53 (Figure S2G) . We also found that upon glucose starvation, when PGC-1a levels are induced PGC-1a interacts with HNF4, which is distinctive of its interaction with p53 ( Figure S2H ). Thus we believe that FOXO1 and HNF4 are not part of the p53-PGC-1a complex. Sirt1 has also been reported to interact with both p53 and PGC-1a (Luo et al., 2001; Vaziri et al., 2001; Rodgers et al., 2005) . Sirt1 interacts with p53 induced under genotoxic stress conditions. Under metabolic stress conditions, Sirt1 has been reported to interact with and deacetylate PGC-1a and promote PGC-1a metabolic functions. In our experimental system we did not see a robust induction of endogenous Sirt1 levels upon glucose deprivation, as has been previously reported (Hou et al., 2008; Pang et al., 2011) , and could not detect its interaction with p53. However, we could detect a weak interaction of Sirt1 with PGC-1a induced under such conditions, which is distinctive of p53-PGC-1a interaction ( Figure S2I ).
In conclusion, our present findings establish that PGC-1a plays a key role in modulating a p53-mediated metabolic stress response that augments cell-cycle arrest and metabolic functions of p53 by promoting preferential transactivation of proarrest and metabolic targets of p53. Our results provide key insights into the regulation of PGC-1a protein which acts as a critical switch in determining p53-mediated cell fate decisions in response to metabolic stress.
EXPERIMENTAL PROCEDURES
Cell Lines and Culture Conditions H1299, SH-SY5Y, and HepG2 cells were cultured in DMEM containing fetal bovine serum (FBS) (Invitrogen). Adenoviruses were amplified and titrated and infections carried out as previously reported (Das and Somasundaram, 2006) . For inducing glucose starvation, cells were grown in glucose-free DMEM (Invitrogen) containing dialysed FBS (Invitrogen) and 5 mM glucose (Sigma). For inducing serum starvation, cells were grown in serum-free DMEM (Invitrogen). Early passage MEFs were cultured and retroviral transduction was carried out as described previously (Jones et al., 2005 ).
Molecular Cell
PGC-1a, a Key Modulator of p53 (A) Total RNA was isolated from hepatocytes of control and PGC-1a siRNA-injected mice after starvation for the indicated number of days. Relative mRNA levels were analyzed by RT-qPCR for the indicated genes. The data shown are representative of three independent experiments using samples from five individual mice. Error bars are means ± SD from five individual mice (n = 5). (B) Control and PGC-1a siRNA-injected mice were starved for the indicated number of days. Hepatocyte lysates were prepared and western blot analysis was performed for the indicated proteins. Data are representative of three independent experiments. (C) ROS levels in hepatocytes isolated from 0, 1, and 3 days starved control and PGC-1a siRNA-injected mice were measured by staining with DCFDA. The data shown are representative of three independent experiments using samples from five individual mice. Error bars are means ± SD from five individual mice (n = 5). (D) Hepatocytes were isolated from 0, 1, and 3 days starved control and PGC-1a siRNA-injected mice, and TUNEL assay was performed. The data shown are representative of three independent experiments using samples from five individual mice. Error bars are means ± SD from five individual mice (n = 5).
PGC-1a, a Key Modulator of p53
Flow Cytometry and TUNEL Assay Cell-cycle analysis using flow cytometry was carried out as described previously (Han et al., 2002) . Apoptosis was detected using TUNEL Assay Kit (Promega). All FACS data were analyzed using FlowJo software.
ROS
The generation of ROS was measured using fluorescent dye DCFDA (Invitrogen) or DHE (Sigma). The cells were incubated with serum-free DMEM containing 10 mM DCFDA at 37 C for 30 min. The cells were then harvested and resuspended in 1 ml of DMEM containing 10% FBS. Samples were analyzed by flow cytometry. For DHE staining, cells were incubated with 2 mM DHE for 15 min at 37 C, washed, resuspended in PBS, and analyzed by flow cytometry. All FACS data were analyzed using FlowJo software.
RT-qPCR
Total RNA was extracted using Trizol (Invitrogen). cDNA synthesis was carried out using iScript cDNA synthesis kit (Bio-Rad) following the manufacturer's protocol. qPCR was then carried out using validated qPCR primers (QIAGEN) and iTaq SYBR Green Supermix (Bio-Rad). 18S rRNA was used as internal control for all samples.
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